Variations in aryl hydrocarbon hydroxylase activities in mitogen-activated human and nonhuman primate lymphocytes. 1984

R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore

A fluorometric assay for the cytochrome P-450-dependent enzyme system, aryl hydrocarbon hydroxylase (AHH), was performed in mitogen-activated human lymphocytes from over 300 different humans and from 64 baboons. Results reveal: a) an average interindividual variation in AHH activity of approximately 0.25 (coefficient of variation); range of activities among humans and baboon subjects of approximately 40-fold; c) both genetic and environmental determinants of interindividual variation, and d) high AHH activity in humans associated with primary lung cancer. Confirmation of these results awaits the development of improved methods for phenotyping humans and for prospective cancer patient studies. DNA probes might be employed in future studies to determine specific mRNA content, and to search for DNA polymorphisms in and near the human cytochrome P-450 gene.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D010215 Papio A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of five named species: PAPIO URSINUS (chacma baboon), PAPIO CYNOCEPHALUS (yellow baboon), PAPIO PAPIO (western baboon), PAPIO ANUBIS (or olive baboon), and PAPIO HAMADRYAS (hamadryas baboon). Members of the Papio genus inhabit open woodland, savannahs, grassland, and rocky hill country. Some authors consider MANDRILLUS a subgenus of Papio. Baboons,Baboons, Savanna,Savanna Baboons,Baboon,Baboon, Savanna,Papios,Savanna Baboon
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003574 Cytochrome c Group A group of cytochromes with covalent thioether linkages between either or both of the vinyl side chains of protoheme and the protein. (Enzyme Nomenclature, 1992, p539) Cytochromes Type c,Group, Cytochrome c,Type c, Cytochromes
D005260 Female Females
D005470 Fluorometry An analytical method for detecting and measuring FLUORESCENCE in compounds or targets such as cells, proteins, or nucleotides, or targets previously labeled with FLUORESCENCE AGENTS. Fluorimetry,Fluorometric Analysis,Analysis, Fluorometric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
November 1979, Cancer research,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
July 1978, Life sciences,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
July 1973, Cancer research,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
August 1976, Biochemical genetics,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
May 1973, American journal of human genetics,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
January 1982, Toxicology,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
July 1981, Cancer research,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
June 1977, Cancer research,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
December 1976, Cancer research,
R E Kouri, and C E McKinney, and A S Levine, and B K Edwards, and E S Vesell, and D W Nebert, and T L McLemore
May 1976, Biochemical and biophysical research communications,
Copied contents to your clipboard!